BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND TRIM27, DASS-46L4_6, RFP, 5987, ENSG00000234495, RNF76 AND Prognosis
4012 results:

  • 1. [Role of neoadjuvant rectal score in prognosis and adjuvant chemotherapy decision-making in locally advanced rectal cancer following neoadjuvant short-course radiotherapy and consolidation chemotherapy].
    Zeng Q; Tang Y; Zhou HT; Li N; Liu WY; Chen SL; Li S; Lu NN; Fang H; Wang SL; Liu YP; Song YW; Li YX; Jin J
    Zhonghua Zhong Liu Za Zhi; 2024 Apr; 46(4):335-343. PubMed ID: 38644269
    [No Abstract]    [Full Text] [Related]  

  • 2. The efficacy and safety of short-course radiotherapy followed by sequential chemotherapy and Cadonilimab for locally advanced rectal cancer: a protocol of a phase II study.
    Xu T; Feng L; Zhang W; Li H; Ma H; Abulimiti M; Tan Y; Deng F; Huang W; Zou S; Kang W; Jiang L; Wang Y; Hu C; Chen Y; Zhou H; Tang Y; Jin J
    BMC Cancer; 2024 Apr; 24(1):501. PubMed ID: 38641773
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Relationship of FDG PET/CT imaging features with tumor immune microenvironment and prognosis in colorectal cancer: a retrospective study.
    Lee JW; Ahn H; Yoo ID; Hong SP; Baek MJ; Kang DH; Lee SM
    Cancer Imaging; 2024 Apr; 24(1):53. PubMed ID: 38627864
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Management and staging of anal adenocarcinoma in the United States: a population-based analysis.
    Troester A; Kohn J; Wang Q; Weaver L; Hassan I; Gaertner W; Marmor S; Goffredo P
    J Gastrointest Surg; 2024 Apr; 28(4):519-527. PubMed ID: 38583905
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Multicentre retrospective analysis on pulmonary metastasectomy: an European perspective.
    Prisciandaro E; Bertolaccini L; Fieuws S; Cara A; Spaggiari L; Huang L; Petersen RH; Ambrogi MC; Sicolo E; Barbarossa A; De Leyn P; Sporici D; Balsamo L; Donlagic A; Gonzalez M; Fuentes-Gago MG; Forcada-Barreda C; Congedo MT; Margaritora S; Belaroussi Y; Thumerel M; Tricard J; Felix P; Lebeda N; Opitz I; De Palma A; Marulli G; Braggio C; Thomas PA; Mbadinga F; Baste JM; Sayan B; Yildizeli B; Van Raemdonck DE; Weder W; Ceulemans LJ
    Eur J Cardiothorac Surg; 2024 Mar; 65(4):. PubMed ID: 38579246
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinicopathological factors predict residual lymph node metastasis in locally advanced rectal cancer with ypT0-2 after neoadjuvant chemoradiotherapy.
    Cui Y; Song M; Tie J; Li S; Wang H; Zhang Y; Geng J; Liu Z; Teng H; Sui X; Zhu X; Cai Y; Li Y; Wang W
    J Cancer Res Clin Oncol; 2024 Apr; 150(4):176. PubMed ID: 38575793
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Impact of severe postoperative complications on the prognosis of older patients with colorectal cancer: a two-center retrospective study.
    Matsubara D; Soga K; Ikeda J; Kumano T; Mitsuda M; Konishi T; Komatsu S; Shimomura K; Taniguchi F; Shioaki Y; Otsuji E
    BMC Gastroenterol; 2024 Apr; 24(1):125. PubMed ID: 38566007
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. XELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer: a multicenter, open-label, randomized, controlled, phase 3 trial.
    Pan QZ; Zhao JJ; Liu L; Zhang DS; Wang LP; Hu WW; Weng DS; Xu X; Li YZ; Tang Y; Zhang WH; Li JY; Zheng X; Wang QJ; Li YQ; Xiang T; Zhou L; Yang SN; Wu C; Huang RX; He J; Du WJ; Chen LJ; Wu YN; Xu B; Shen Q; Zhang Y; Jiang JT; Ren XB; Xia JC
    Signal Transduct Target Ther; 2024 Apr; 9(1):79. PubMed ID: 38565886
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [colorectal adenocarcinoma with enteroblastic differentiation: a clinicopathological analysis of eight cases].
    Wang Q; Zhang Y; Tan C; Ni SJ; Huang D; Chang B; Sheng WQ; Wang L
    Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):370-376. PubMed ID: 38556821
    [No Abstract]    [Full Text] [Related]  

  • 10. mFOLFIRINOX versus mFOLFOX 6 as adjuvant treatment for high-risk stage III colon cancer - the FROST trial: study protocol for a multicenter, randomized controlled, phase II trial.
    Lee KH; Yang IJ; Ha GW; Lee J; Park YY; Lee SH; Lee JM; Bae JH; Park EJ; Kim H; Kim KY; An S; Kim IY; Kim JY
    BMC Cancer; 2024 Mar; 24(1):397. PubMed ID: 38553680
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Predicting Complete Pathological Response in Rectal cancer Patients Receiving Neoadjuvant Chemoradiotherapy.
    Karaca M; Salim E; Alemdar MS; Deniz Karaca Ö; Arıcı MÖ
    Med Sci Monit; 2024 Mar; 30():e943750. PubMed ID: 38544312
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. High-risk Patients With colorectal Liver Metastases Assessed by the Beppu Score Can Have Excellent Survival Through Multidisciplinary Treatment Including Local Ablation.
    Beppu T; Yamamura K; Masuda T; Miyamoto H; Nasu J; Saito S; Doi K; Katsumori T; Oda T; Isiko T
    Anticancer Res; 2024 Apr; 44(4):1533-1539. PubMed ID: 38537970
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Effect of the SARS-CoV-2 pandemic on colorectal cancer diagnosis and prognosis.
    Medina-Prado L; Sala-Miquel N; Aicart-Ramos M; López-Cardona J; Ponce-Romero M; Ortíz O; Pellisé M; Aguilera L; Díez-Redondo P; Núñez-Rodríguez H; Seoane A; Domper-Arnal MJ; Borao-Laguna C; González-Bernardo Ó; Suárez A; Muñoz-Tornero M; Bustamante-Balén M; Soutullo-Castiñeiras C; Balleste-Peris B; Esteban P; Jiménez-Gómez M; Albert M; Lucas J; Valdivieso-Cortázar E; López-Serrano A; Solano M; Tejedor-Tejada J; Trelles M; Zapater P; Jover R
    Cancer Med; 2024 Mar; 13(5):e6923. PubMed ID: 38491824
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Palliative primary tumor resection may not offer survival benefits for patients with unresectable metastatic colorectal neuroendocrine neoplasms, one multicenter retrospective cohort study.
    Yu G; Liu S; Wang Z; Liu Q; Ren H; Hu W
    BMC Surg; 2024 Mar; 24(1):85. PubMed ID: 38475759
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Identification of Novel Prognostic Biomarkers for colorectal cancer by Bioinformatics Analysis.
    Niu C; Li X; Lei Luo X; Wan H; Jin W; Zhang Z; Zhang W; Li B
    Turk J Gastroenterol; 2024 Jan; 35(1):61-72. PubMed ID: 38454278
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Chemotherapy re-use versus anti-angiogenic monotherapy as the third-line treatment of patients with metastatic colorectal cancer: a real-world cohort study.
    Duan J; Zhu L; Shi Y; Wang W; Wang T; Ning T; Zhang L; Bai M; Li H; Liu R; Ge S; Wang X; Yang Y; Ji Z; Wang F; Sun Y; Ba Y; Deng T
    BMC Cancer; 2024 Mar; 24(1):302. PubMed ID: 38443891
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Pulse pressure variation guided goal-direct fluid therapy decreases postoperative complications in elderly patients undergoing laparoscopic radical resection of colorectal cancer: a randomized controlled trial.
    Wu QR; Zhao ZZ; Fan KM; Cheng HT; Wang B
    Int J Colorectal Dis; 2024 Mar; 39(1):33. PubMed ID: 38436757
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Long-term prognosis after stapled and hand-sewn ileal pouch-anal anastomoses for familial adenomatous polyposis: a multicenter retrospective study.
    Tatsuta K; Sakata M; Iwaizumi M; Okamoto K; Yoshii S; Mori M; Asaba Y; Harada T; Shimizu M; Kurachi K; Takeuchi H
    Int J Colorectal Dis; 2024 Mar; 39(1):32. PubMed ID: 38431759
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Siglec9 + tumor-associated macrophages predict prognosis and therapeutic vulnerability in patients with colon cancer.
    Chang J; Feng Q; Mao Y; Zhang Z; Xu Y; Chen Y; Zheng P; Lin S; Shen F; Zhang Z; Zhang Z; He G; Xu J; Wei Y
    Int Immunopharmacol; 2024 Mar; 130():111771. PubMed ID: 38430807
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Construction of an immune predictive model and identification of TRIP6 as a prognostic marker and therapeutic target of CRC by integration of single-cell and bulk RNA-seq data.
    Liu W; Luo X; Zhang Z; Chen Y; Dai Y; Deng J; Yang C; Liu H
    Cancer Immunol Immunother; 2024 Mar; 73(4):69. PubMed ID: 38430268
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 201.